Robert Barrow
CIK 1897557 · Chief Executive Officer · last filed 2026-03-26
Robert Barrow is a Chief Executive Officer who has filed 37 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider sold $451.2K of DFTX on Mar 26, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.62M
2
37
-$2.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DFTX | Chief Executive Officer | 752,454 | $24.75 | $18.62M | -$451.2K | 2 | 2026-03-26 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Chief Executive Officer | 778,477 | $15.00 | $11.68M | -$1.77M | 35 | 2025-12-29 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-26 | DFTX | Sell (S) | −24,431 | -$451.2K | EDGAR |
| 2026-02-05 | DFTX | Grant (A) | +320,000 | $0 | EDGAR |
| 2025-12-29 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −25,791 | -$339.1K | EDGAR |
| 2025-09-26 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −25,797 | -$252.0K | EDGAR |
| 2025-06-26 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −26,491 | -$180.1K | EDGAR |
| 2025-03-26 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −21,208 | -$142.9K | EDGAR |
| 2025-03-13 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +350,000 | $0 | EDGAR |
| 2024-12-27 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −19,106 | -$142.0K | EDGAR |
| 2024-09-25 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −19,771 | -$118.2K | EDGAR |
| 2024-08-20 | Definium Therapeutics, Inc. (MNMD) Delisted | Buy (P) | +1,000 | $6.2K | EDGAR |